Health News Releases

  • Today May 22
May 14, 2015 13:55
DuBiotech Welcomes Germany’s B.Braun
Dubai Biotechnology and Research Park (www.dubiotech.ae) (DuBiotech), a free zone dedicated to facilitating and fostering growth in the UAE’s life sciences industry, today announced that B.Braun (www.
May 14, 2015 12:00
Merck and Pfizer to Present Data at ASCO for Avelumab, an Investigational Anti-PD-L1 Antibody
Merck and Pfizer today announced multiple presentations on studies evaluating the preliminary safety and efficacy of avelumab* at the 2015 American Society of Clinical Oncology (ASCO) annual meeting.
May 14, 2015 11:40
First patient enrolled in dabigatran study comparing anticoagulation strategies during AF ablation
The first patient with atrial fibrillation (AF) has been enrolled in the global RE-CIRCUIT™ study.[4] The study assesses the safety and efficacy of uninterrupted anticoagulation with dabigatran etexil
May 13, 2015 10:30
Takeda Announces First Patient Enrolled in Global Phase 3 Study of Ixazomib as Maintenance Therapy for Newly Diagnosed Multiple Myeloma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the first patient has been enrolled in the Phase 3 TOURMALINE-MM4 study of investigational oral ixazomib. This is a superiority s
May 08, 2015 10:30
Applications Open for 2015 Terumo BCT Advancing Apheresis Award
Terumo BCT, a global medical device manufacturing company, is seeking applications from around the world for a $10,000 grant to further the practice and positive impact of therapeutic apheresis. The T
May 06, 2015 16:55
Teva Provides Additional Detail on Proposed Acquisition of Mylan
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)(TASE:TEVA) today announced that an updated investor presentation in connection with its proposed combination with Mylan N.V. (NASDAQ: MYL) is available
May 06, 2015 10:40
Quintiles Establishes Bioanalytical Laboratory in Europe
Quintiles today announced the expansion of its bioanalytical laboratory services with the establishment of a GLP-compliant bioanalytical liquid chromatography-mass spectrometry (LC-MS) laboratory. The
May 06, 2015 07:00
Final Countdown to World’s Largest Integrated Healthcare Industry Event tHIS
With only days to go to the grand launch of The Health Industry Summit (tHIS) in Shanghai, China, the excitement and anticipation is building up to what is the largest health industry event in the wor
May 01, 2015 13:55
Quintiles Named to InformationWeek Elite 100
Quintiles, the world’s largest biopharmaceutical services company, has been named to the InformationWeek Elite 100 (http://goo.gl/Wc16qk), a ranking of the top business technology innovators in the U.
May 01, 2015 12:00
Teva Sends Letter to Mylan Board
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that it has sent a letter to Robert J. Coury, Executive Chairman of the Board of Directors of Mylan N.V. (NASDAQ: MYL). The fu
April 28, 2015 13:55
Teva Reiterates Commitment to Cash-and-Stock Acquisition of Mylan for $82.00 Per Share
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reiterated its commitment to its proposed combination with Mylan N.V. (NASDAQ: MYL). As previously announced on April 21, 2015, Teva has
April 28, 2015 13:45
ElectroCore’s non-invasive vagus nerve stimulation therapy shown to be safe and to produce no meaningful cardiac adverse effects
At the 67th American Academy of Neurology meeting in Washington, DC, last week a poster presentation showed that electroCore’s non-invasive vagus nerve stimulation (nVNS) therapy does not cause any me
April 27, 2015 13:40
Jean Boulle Group Announces First US Clinical Trial
Boulle Medtech Ltd, a Jean Boulle Group medical technology company and the founding investor of Tendyne Holdings, Inc. (“Tendyne”), is pleased to announce that the Tendyne Transcatheter Mitral Valve I
April 23, 2015 10:10
Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) (TASE:TEVA) today announced that it has filed for premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U
April 23, 2015 09:55
Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced a proposal to acquire all of the outstanding shares of Mylan N.V. (NASDAQ: MYL) in a transaction valued at $82.00 per Mylan sh
April 21, 2015 15:30
4SC Signs Licensing and Development Agreement with Menarini for Resminostat in Asia-Pacific Excluding Japan
4SC AG (Frankfurt, Prime Standard: VSC), a discovery and development company of targeted small molecule drugs for cancer and autoimmune diseases, and Singapore based Menarini Asia-Pacific Holdings Pte
April 21, 2015 12:00
Global Trials Show Addition of Medtronic’s Solitaire™ Device Stent Thrombectomy Procedure in Treatment of Acute Ischemic Stroke Improves Neurological Outcomes
Two global trials published online in The New England Journal of Medicine (NEJM) and presented at the European Stroke Organisation Conference (http://eso.kenes.com) found that the addition of the Soli
April 20, 2015 15:20
Applied Spectral Imaging Received South Korean Ministry of Food and Drug Safety (MFDS) Clearance for GenASIs™ HiPath IHC Family for HER2, ER, PR and Ki67
Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced today that it has received clearance from the South Korean Ministry of Food and Drug Safety (MFDS) for its GenASIs HiPath image captu
April 20, 2015 10:15
New international survey of lung cancer oncologists highlights underutilization of personalized treatments
For media outside the US, the UK and Canada only Results from a new global survey of lung cancer oncologists have shown that despite 81% of newly diagnosed advanced non-small cell lung cancer (NSCL
April 17, 2015 13:55
Quintiles and Hospital Italiano of Buenos Aires Announce Agreement to Accelerate Clinical Development
Quintiles today announced a strategic alliance with Hospital Italiano of Buenos Aires as part of the company’s Prime Site program. Hospital Italiano is Quintiles’ first Prime Site in Latin America, co
April 16, 2015 11:20
Phase II Data for Apremilast in Behçet’s Disease Published in The New England Journal of Medicine
Celgene Corporation (NASDAQ:CELG) today announced that results from a multicenter, randomized, placebo-controlled phase II trial (BCT-001) of apremilast (Otezla®) in patients with Behçet’s disease wer
April 15, 2015 11:20
IncellDx, Inc. Signs Exclusive License with Claremont BioSolutions to Commercialize Novel Liquid-Based Biopsy Technology
IncellDx, Inc. announced today the signing of a worldwide, exclusive license and supply agreement with Claremont BioSolutions (Upland, CA) to couple their enzyme-free tissue homogenization technology
April 14, 2015 19:00
WIN Consortium Appoints Professor Waun Ki Hong as Special Advisor to Oversee Its Combined Targeted Triple-Therapy Strategy Aiming to Achieve Significant Impact on Survival in Metastatic Lung Cancer
Worldwide Innovative Networking - WIN Consortium (www.winconsortium.org) announces today the appointment of Professor Waun Ki Hong from the University of Texas MD Anderson Cancer Center, as Special Ad
April 14, 2015 10:35
Hydra Biosciences and Boehringer Ingelheim Enter Research Collaboration Focused on Renal Diseases and Disorders
Hydra Biosciences, Inc., a leader in the field of transient receptor potential (TRP) channel modulation, and Boehringer Ingelheim today announced that they have entered into a worldwide research colla
April 10, 2015 19:00
Replicor to Present at the 2015 Lancet Viral Hepatitis Conference
Replicor Inc., a privately held biopharmaceutical company targeting a cure for patients with chronic hepatitis B (HBV) and hepatitis D (HDV) infection, today announced that it will present updated cli
25 per page50 per page75 per page100 per page